Sign in

CIK 0001677077

  • Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
811822909
Phone
+1 844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
  1. 4 Open-market buy 10% owner bought 16,400 shares at an average $3.62 ($59,379)
  2. 4 Open-market buy 10% owner bought 5,600 shares at an average $4.06 ($22,715)
  3. 4 Open-market buy 10% owner bought 1,500 shares at an average $4.24 ($6,360)
  4. 4 Open-market buy 10% owner bought 1,340,333 shares at an average $1.52 ($2,031,863)
  5. 4 Open-market buy 10% owner bought 12,500 shares at an average $5.08 ($63,554)
  6. 4 Open-market buy 10% owner bought 3,000 shares at $5.20 ($15,605)
  7. 4 Open-market buy 10% owner bought 5,300 shares at an average $5.63 ($29,818)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4/A Open-market buy 10% owner bought 14,500 shares at an average $6.15 ($89,136)
  13. 4 Open-market buy 10% owner bought 14,000 shares at an average $6.37 ($89,136)
  14. 4 Open-market buy 10% owner bought 14,000 shares at an average $6.65 ($93,109)
  15. 4 Open-market buy 10% owner bought 26,000 shares at an average $7.53 ($195,661)
  16. 4 Open-market buy 10% owner bought 24,300 shares at an average $9.15 ($222,339)
  17. 4 Open-market buy 10% owner bought 12,000 shares at an average $8.39 ($100,680)
  18. 4 Open-market buy 10% owner bought 74,000 shares at an average $9.29 ($687,117)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy 10% owner bought 2,000,000 shares at $5.00 ($10,000,000)

Page 8 of 9 · 170 filings